Age-related macular degeneration (AMD) affects more than 5 million people around the world. And until now, no treatment could restore their vision. The Prima system, which was approved in Europe in July and is awaiting FDA clearance in the US, changes that. It combines a retinal implant with camera-equipped eyeglasses to improve sight in patients…
Royalties, speaking fees and course sales are only a fraction of what your expertise is worth, and the biggest returns show up in places your CRM will never track.
nthropic has committed $11.6 billion over seven years to Akamai’s cloud infrastructure, a bet on CPUs that could grow to about $20 billion, and in an unusual arrangement, Akamai is giving Anthropic a potential stake of up to 5% of its stock that grows as Anthropic spends more.